Published in Biotech Business Week, June 15th, 2006
All securities are classified according to the Industry Classification Benchmark (ICB) as either biotechnology or pharmaceutical. The securities that meet the classification criteria then must meet other index eligibility criteria including listing on the Nasdaq National Market and meeting minimum requirements for market value, average daily share volume and seasoning as a public company.
As a result of the re-ranking, Accelrys, Inc. (ACCL), Affymetrix, Inc. (AFFX),...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.